Both gene mutations and copy number alterations (gains and losses) have been described in a wide variety of sporadic cancers of different origin (65% of 10,202 cancers from the TCGA database; [148]), with overexpression being attributed to coordinated regulation through the Rb/E2F pathway [149]. Here, RB1 is linked to cancer.